Overview

Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Status:
Completed
Trial end date:
2017-12-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy of orlistat 60 mg as adjuvant treatment of Obesity in adults.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Orlistat